FDA Reopening Comment Period for Notice of Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research

“FDA is reopening the comment period for the notice of public meeting entitled ‘Human Immunodeficiency Virus (HIV) Patient-Focused Drug Development and HIV Cure Research,’ published in the Federal Register of May 21, 2013. As part of Patient-Focused Drug Development, FDA is gathering input from HIV patients and patient advocates on current approaches to managing HIV, symptoms experienced because of HIV or its treatment, and patient perspectives related to ‘HIV cure research.’ “Comments can be submitted until September 3, 2013.” For more information and to learn how to submit comments, read the FDA press release or view the notice at FederalRegister.gov.